Any current/future new fundraising through debt or equity?

The company currently has approximately $50 million of debt remaining, which they prioritize paying down quickly. There is no explicit mention of immediate plans for new fundraising through either debt or equity. Management emphasized cautiousness regarding acquisitions due to current market valuations but remain open to inorganic growth opportunities. Priorities in the near term are focused on debt repayment, organic growth, and complementary acquisitions rather than raising new capital. No dividend policy announced yet, as focus remains on growth and debt reduction.

Future growth expectations in sales/revenue/volumes?

The company aims to grow faster than the outsourced TAM growth rate of 12% to gain market share. Current quarterly growth was 24% year-on-year in revenue with only 1.5% headcount growth, indicating strong tech leverage. Expectation of continued industry-leading growth driven by expanding existing customer feature penetration and new deal conversions. Growth will be fueled by platform expansion, cross-selling in large customers, and penetration into new market segments. Revenue from recent deals (e.g., Femwell, StrideCare) expected to start contributing from Q4 FY26 onwards and ramp through nex

Future growth expectations in earnings/operating earnings/profits/EPS?

The company aims to grow faster than the market (12% TAM growth) to gain market share but cautions growth will not be linear given market dynamics and regulatory unpredictability. EBITDA margins are expected to stabilize in the early to mid-30% range; significant margin expansion at the EBITDA level is not anticipated, but gross margin optimizations will continue. R&D and sales & marketing investments will increase to drive long-term growth and platform development, especially in AI and automation. Adjusted PAT grew 48% year-on-year this quarter, and EPS grew 40% year-on-year, reflecting

Current/ Expected Orderbook/ Pending Orders?

The transcript does not provide specific details or quantitative figures regarding the current or expected order book or pending orders. The company discusses strong execution and continued growth with significant platform sales in small to mid-size markets. They highlight a strategic pivot to balancing platform and point-solution sales across different customer segments. The management emphasizes ongoing customer expansions, with 85%-90% of growth coming from existing customers. New deals from earlier announcements are expected to translate into revenue over the coming quarters. No explicit m

IN US

Sale is live|00:00:00left today

Inventurus Knowledge Solutions LtdQ4 FY27IT - Services

Inventurus Knowledge Solutions Ltd Q4 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,718P/E: 38.0Market Cap: ₹27.4K CrSector: IT - Services

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

→The company aims to grow faster than the outsourced TAM growth rate of 12% to gain market share.
→Current quarterly growth was 24% year-on-year in revenue with only 1.5% headcount growth, indicating strong tech leverage.
→Expectation of continued industry-leading growth driven by expanding existing customer feature penetration and new deal conversions.
→Growth will be fueled by platform expansion, cross-selling in large customers, and penetration into new market segments.
→Revenue from recent deals (e.g., Femwell, StrideCare) expected to start contributing from Q4 FY26 onwards and ramp through next quarters.
→The market is highly dynamic; growth may not be linear quarter-over-quarter but maintains an overall positive trajectory.
→Investments in R&D and sales force expansion will continue to support growth and market penetration.
→Growth beyond 12% indicates gaining market share; below 12% means losing market share.

Margin guidance

Category 3

→The company aims to grow faster than the market (12% TAM growth) to gain market share but cautions growth will not be linear given market dynamics and regulatory unpredictability.
→EBITDA margins are expected to stabilize in the early to mid-30% range; significant margin expansion at the EBITDA level is not anticipated, but gross margin optimizations will continue.
→R&D and sales & marketing investments will increase to drive long-term growth and platform development, especially in AI and automation.
→Adjusted PAT grew 48% year-on-year this quarter, and EPS grew 40% year-on-year, reflecting strong profitability expansion.
→Operating cash flow (OCF) and free cash flow (FCF) conversions from EBITDA and PAT remain very healthy and close to 100%.
→Revenue growth will be supported by both new client acquisitions and strong expansion within existing customers (85%-90% growth from existing client expansions).
→Currency headwinds and technology cost fluctuations may impact R&D and margins intermittently.

3 more insights locked — sign up free to unlock

Fundraise plans

→The company currently has approximately $50 million of debt remaining, which they prioritize paying down quickly.
→There is no explicit mention of immediate plans for new fundraising through either debt or equity.
→Management emphasized cautiousness regarding acquisitions due to current market valuations but remain open to inorganic growth opportunities.
→Priorities in the near term are focused on debt repayment, organic growth, and complementary acquisitions rather than raising new capital.
→No dividend policy announced yet, as focus remains on growth and debt reduction.

Order book

→The transcript does not provide specific details or quantitative figures regarding the current or expected order book or pending orders.
→The company discusses strong execution and continued growth with significant platform sales in small to mid-size markets.
→They highlight a strategic pivot to balancing platform and point-solution sales across different customer segments.
→The management emphasizes ongoing customer expansions, with 85%-90% of growth coming from existing customers.
→New deals from earlier announcements are expected to translate into revenue over the coming quarters.
→No explicit mention is made of order backlog or pending orders in the provided transcript segment.

Capex plans

Yes

- The company plans to continue investing significantly in R&D, especially in AI and technology to enhance their platform and automation capabilities. - R&D investment is expanding, with recent quarter R&D spend at about 4.7% of revenue (~INR 39 crores). - Capital expenditure is indirectly referenced through investments in technology infrastructure (systems of compute and logic). - No explicit mention of large one-time capital expenditures or strategic acquisitions in the near term, but leadership remains open to acquisitions especially in point solution system of action in health markets, subject to valuation caution. - Near term priorities include paying down $50 million of existing debt quickly before pursuing aggressive capital or strategic investments. - Focus on expanding sales, marketing, and platform development rather than margin expansion, indicating investment-driven growth strategy. - No declared dividend policy, reflecting reinvestment focus. Overall, strategic investments are technology and capability-driven with measured outlook on acquisitions and capital allocation.

How does Inventurus Knowledge Solutions Ltd rank vs peers in IT - Services?

Pro feature

1Inventurus Knowledge Solutions Ltd

Rev 3Mar 3

See full IT - Services sector rankings

Want more stocks like Inventurus Knowledge Solutions Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio